Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP744353.RA1sxs-CIacmduMFLGbI66X0DkFHfAHx6kEIHMt3FIKKE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP744353.RA1sxs-CIacmduMFLGbI66X0DkFHfAHx6kEIHMt3FIKKE130_assertion type Assertion NP744353.RA1sxs-CIacmduMFLGbI66X0DkFHfAHx6kEIHMt3FIKKE130_head.
- NP744353.RA1sxs-CIacmduMFLGbI66X0DkFHfAHx6kEIHMt3FIKKE130_assertion description "[However, recent reports of myelodysplastic syndrome/acute myeloid leukemia (t-MDS/AML) developing after treatment with immunosuppressants and G-CSF has raised concern over the use of this agent in patients with aplastic anemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP744353.RA1sxs-CIacmduMFLGbI66X0DkFHfAHx6kEIHMt3FIKKE130_provenance.
- NP744353.RA1sxs-CIacmduMFLGbI66X0DkFHfAHx6kEIHMt3FIKKE130_assertion evidence source_evidence_literature NP744353.RA1sxs-CIacmduMFLGbI66X0DkFHfAHx6kEIHMt3FIKKE130_provenance.
- NP744353.RA1sxs-CIacmduMFLGbI66X0DkFHfAHx6kEIHMt3FIKKE130_assertion SIO_000772 14607763 NP744353.RA1sxs-CIacmduMFLGbI66X0DkFHfAHx6kEIHMt3FIKKE130_provenance.
- NP744353.RA1sxs-CIacmduMFLGbI66X0DkFHfAHx6kEIHMt3FIKKE130_assertion wasDerivedFrom befree-20140225 NP744353.RA1sxs-CIacmduMFLGbI66X0DkFHfAHx6kEIHMt3FIKKE130_provenance.
- NP744353.RA1sxs-CIacmduMFLGbI66X0DkFHfAHx6kEIHMt3FIKKE130_assertion wasGeneratedBy ECO_0000203 NP744353.RA1sxs-CIacmduMFLGbI66X0DkFHfAHx6kEIHMt3FIKKE130_provenance.